Novo Nordisk is About to Become Europe's Most Valuable Company as the Weight-Loss Drug Ozempic Sees Soaring Demand
With the collective girth of the Western world continuing to expand, Novo Nordisk is benefitting massively from Ozempic's soaring demand.
Source: wccftech.com